Application 207061
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 50MG | No | No |
| 002 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 100MG | No | No |
| 003 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 200MG | No | No |
| 004 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207061-001 | CELECOXIB | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | ||
| A207061-002 | CELECOXIB | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | ||
| A207061-003 | CELECOXIB | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | ||
| A207061-004 | CELECOXIB | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207061-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2017-04-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207061-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2017-04-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207061-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2017-04-04 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207061-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2017-04-04 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A207061-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207061-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207061-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207061-004 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207061-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207061-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207061-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207061-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207061-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207061-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207061-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A207061-004 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207061-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A207061-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A207061-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A207061-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207061-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A207061-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A207061-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A207061-004 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A207061-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A207061-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A207061-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A207061-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207061-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A207061-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A207061-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A207061-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207061-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A207061-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A207061-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A207061-004 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| celecoxib | CELECOXIB | Asclemed USA, Inc. | 2a926010-08e1-44dd-bc6d-ed15374bd0d3 | 2023-09-02 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 00e67d5e-df6f-4dfd-8c2d-a001c8a99af0 | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| Celecoxib | CELECOXIB | A-S Medication Solutions | dea035a6-dcf1-4b7d-8adc-a2f678b71fd9 | 2023-08-06 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Proficient Rx LP | b9a7f32c-8136-4f29-be6b-4d5e904ca0f1 | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | c7a183dc-f4d5-483f-964c-f2745a3640ad | 2023-02-28 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| celecoxib | CELECOXIB | A-S Medication Solutions | 85bfe02b-bfcb-44ee-81a0-11765c3054a9 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| celecoxib | CELECOXIB | Proficient Rx LP | 0ad14a4e-2f05-4ce7-93d1-1cb7e4d8f7d0 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| celecoxib | CELECOXIB | Proficient Rx LP | cbd2d6de-6f0d-4b69-8e27-a1fe08830ba5 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Tianjin Tianyao Pharmaceuticals Co., Ltd. | 76f9bcb7-0e94-485f-816d-61d4e1ed24e0 | 2022-02-28 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Aphena Pharma Solutions - Tennessee, LLC | d258e065-e9a6-44e2-89c9-6892d771d9d3 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | Proficient Rx LP | c91e5933-1798-4096-9f08-fb1200e154e1 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| Celecoxib | CELECOXIB | Proficient Rx LP | 6dd743d3-4821-4919-90eb-6d306ca7999f | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib 200 mg | CELECOXIB | Proficient Rx LP | feee6a01-63f9-42c3-8bd8-ca713a08b36d | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB |
| Celecoxib | CELECOXIB | Proficient Rx LP | 7a234c0c-30a7-49f5-92a1-a1fc836ff9ae | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Proficient Rx LP | c787b0ab-77ab-4f7e-9fea-be2a0085020a | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 59746-561 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-561 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-561 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-561 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-561 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-562 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-562 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-562 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-562 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-562 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-563 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-563 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-563 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-563 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-563 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-564 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-564 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-564 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-564 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |
| 59746-564 | Celecoxib | Celecoxib | Jubilant Cadista Pharmaceuticals Inc. | ANDA | Current |